Vimarsana
Biggest News Aggregation in the World

Page 20 - Randomized Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Randomized Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Randomized Trial Today - Breaking & Trending Today

'Significant differences' exist in COVID-19 vaccination rates among people with HIV - Vimarsana News

'Significant differences' exist in COVID-19 vaccination rates among people with HIV

COVID-19 vaccination rates differ significantly among people with HIV, researchers found. According to a study published in the Journal of Infectious Diseases, factors that influence these differences include age, race, sex, body mass index and country of residence.

Source: healio.com
Study analyzes global COVID-19 vaccination rates among people living with HIV - Vimarsana News

Study analyzes global COVID-19 vaccination rates among people living with HIV

COVID-19 vaccination is especially important for immunocompromised individuals, such as people living with HIV, who face higher risks of developing severe symptoms and dying from COVID-19.

Frontiers | Chagas Disease Drug Discovery in Latin America—A Mini Review of Antiparasitic Agents Explored Between 2010 and 2021 - Vimarsana News

Frontiers | Chagas Disease Drug Discovery in Latin America—A Mini Review of Antiparasitic Agents Explored Between 2010 and 2021

Chagas disease is a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi that endangers almost 70 million people worldwide. The only two drugs that are currently approved for its treatment, benznidazole and nifurtimox, have controversial efficacy in adults and restricting safety issues, leaving thousands of patients without a suitable treatment. The neglect of Chagas disease is further illustrated by the lack of a robust and diverse drug discovery and development portfolio of new chemical entities, and it is of paramount importance to build a strong research and develo...

FFR-Guided PCI Falls Short vs CABG in Multivessel CAD: FAME 3 - Vimarsana News

FFR-Guided PCI Falls Short vs CABG in Multivessel CAD: FAME 3

PCI guided by fractional flow reserve assessment may have yielded better outcomes in patients with less complex coronary anatomy, researchers say; others doubt the appropriateness of the subgroup analysis.

Royal Philips: TCT 2021: Philips announces new innovations and clinical data supporting the treatment of patients with cardiovascular disease - Vimarsana News

Royal Philips: TCT 2021: Philips announces new innovations and clinical data supporting the treatment of patients with cardiovascular disease

November 2, 2021 Philips debuts three new solutions in the North American market that will help drive procedural innovation and workflow efficiency, adding to the company's ecosystem of interventional